Histone deacetylase adaptation in single ventricle heart disease and a young animal model of right ventricular hypertrophy
Open Access
- 21 June 2017
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 82 (4) , 642-649
Abstract
Background Histone deacetylase (HDAC) inhibitors are promising therapeutics for various forms of cardiac diseases. The purpose of this study was to assess cardiac HDAC catalytic activity and expression in children with single ventricle (SV) heart disease of right ventricular morphology, as well as in a rodent model of right ventricular hypertrophy (RVH). Methods Homogenates of right ventricle (RV) explants from non-failing controls and children born with a SV were assayed for HDAC catalytic activity and HDAC isoform expression. Postnatal 1-day-old rat pups were placed in hypoxic conditions, and echocardiographic analysis, gene expression, HDAC catalytic activity, and isoform expression studies of the RV were performed. Results Class I, IIa, and IIb HDAC catalytic activity and protein expression were elevated in the hearts of children born with a SV. Hypoxic neonatal rats demonstrated RVH, abnormal gene expression, elevated class I and class IIb HDAC catalytic activity, and protein expression in the RV compared with those in the control. Conclusions These data suggest that myocardial HDAC adaptations occur in the SV heart and could represent a novel therapeutic target. Although further characterization of the hypoxic neonatal rat is needed, this animal model may be suitable for preclinical investigations of pediatric RV disease and could serve as a useful model for future mechanistic studies.Keywords
This publication has 40 references indexed in Scilit:
- Emerging beneficial roles of sirtuins in heart failureBasic Research in Cardiology, 2012
- Selective Class I Histone Deacetylase Inhibition Suppresses Hypoxia-Induced Cardiopulmonary Remodeling Through an Antiproliferative MechanismCirculation Research, 2012
- Cardiac HDAC6 catalytic activity is induced in response to chronic hypertensionJournal of Molecular and Cellular Cardiology, 2011
- Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagyProceedings of the National Academy of Sciences, 2011
- HDAC Inhibition Attenuates Inflammatory, Hypertrophic, and Hypertensive Responses in Spontaneously Hypertensive RatsHypertension, 2010
- Comparison of Shunt Types in the Norwood Procedure for Single-Ventricle LesionsNew England Journal of Medicine, 2010
- HDAC6 Regulates Mitochondrial Transport in Hippocampal NeuronsPLOS ONE, 2010
- Histone deacetylase inhibition reduces myocardial ischemia‐reperfusion injury in miceThe FASEB Journal, 2008
- HDAC4 and PCAF Bind to Cardiac Sarcomeres and Play a Role in Regulating Myofilament Contractile ActivityJournal of Biological Chemistry, 2008
- Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic SyndromesClinical Cancer Research, 2008